-
Big Data Holds Key to Life Saving Discoveries Says Kiwi Whitepaper
Auckland, New Zealand, 14th December 2016 / Sciad Newswire / A whitepaper released today by bioinformatics technology company Biomatters examines the critical role big data will play in enabling scientists to discover life saving biologic drugs of the future. The whitepaper discusses how technology innovations such as high-throughput DNA sequencing have created a big data challenge and opportunity for enterprises involved in monoclonal antibody (mAb) therapeutic development. Today,…
-
Domainex Invests in NanoTemper MicroScale Thermophoresis Technology to Advance its Fragment-based Drug Discovery Services
Saffron Walden, UK, 15th December 2016 / Sciad Newswire / Domainex Ltd announces today that it has purchased and fully commissioned a Monolith NT.Automated instrument from NanoTemper Technologies Ltd. As the first UK contract research organisation to invest in the instrument, Domainex is in a unique position to offer its partners and clients improved fragment-based drug discovery (FBDD) services…
-
Bio-start Competition Announces Additional Cash Prizes and Sponsors
London, UK, 13th December 2016 / Sciad Newswire / SynbiCITE and Rainbow Seed Fund today announce new sponsors and prizes for the Bio-start competition, designed to commercialise the engineering of biology. The addition of new sponsors increases the number of prizes available to competitors including the free use of laboratory space around the UK. Steve Chambers, CEO of SynbiCITE, explained: “We’ve…
-
DNA2.0, Inc. Becomes ATUM
Newark, CA, USA, 12th December 2016 / Sciad Newswire / Founded in 2003 to marry computational design and gene synthesis, DNA2.0 was a pioneer in the application of machine learning (or artificial intelligence) to biology. Today, the company is building on that legacy of invention with a new name: ATUM. In Egyptian mythology, ATUM was the…
-
Synpromics Announces Expansion of Research Collaboration with Adverum Biotechnologies
Edinburgh, UK, 7th December 2016 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to expand the research collaboration with Adverum Biotechnologies that began in December 2015. The initial collaboration focused on using Synpromics technology to develop promoters for the treatment of eye diseases, and has yielded promising early results. The…
-
Synpromics announces collaboration with Sartorius Stedim Cellca to develop improved biologicals manufacturing process using synthetic promoters
Edinburgh, UK, 5th December 2016 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a collaboration with Sartorius Stedim Cellca (Cellca) to evaluate and test its customised synthetic promoters with Sartorius’ proprietary mammalian production cell platform. The goal of the programme is to reduce timelines and increase yields in…
-
Vital debate at Pharma Integrates 2016
The 5th annual Pharma Integrates conference saw industry leaders from across the UK and Europe meet to debate the challenges and opportunities faced by the Pharmaceutical industry today. Led by over 70 prestigious speakers, joined by 250 senior industry executives, established paradigms were challenged and new operational models for the industry were discussed. Putting patients first…
-
SynbiCITE response to Government announcement on extra investment for science
London, UK, 22nd November 2016 / Sciad Newswire / SynbiCITE welcomes yesterday’s announcement by the Government of an additional £2billion investment per year for UK science R&D by the end of this parliament. The promise of support and investment in science and technology innovation through an industrial strategy is also very encouraging and we look forward to hearing more….
-
The New Domainex Medicines Research Centre is Opened by Sir Simon Campbell
Saffron Walden, UK, 17th November 2016 / Sciad Newswire / Saffron Walden, UK, 17th November 2016 / Sir Simon Campbell, CBE FRS FMedSci, was welcomed by staff and guests when he officially opened The Domainex Medicines Research Centre on Friday 11th November 2016. The new facility, located at Chesterford Research Park, has been home to Domainex since August…
-
Pharma Integrates 2016 Reaches New Heights
London, UK, 17th November 2016 / Sciad Newswire / The pharmaceutical industry is a sector of strategic importance, standing on the threshold of innovation, said Mike Thompson, Chief Executive, ABPI, as he welcomed 350 delegates to Pharma Integrates 2016. With an impressive line-up of more than 70 speakers, senior level delegates from every part of the pharmaceutical industry and…